Search

Search Constraints

You searched for: Author/Creator Silletta, Marianna

Search Results

1. Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib. (22nd July 2021)

3. Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population. (February 2023)

5. Exploring the efficacy and safety of single-agent sorafenib in a cohort of Italian patients with hepatocellular carcinoma. Issue 10 (October 2012)

6. Multicenter prospective study of angiogenesis polymorphism validation in HCC patients treated with sorafenib. An INNOVATE study protocol. Issue 6 (December 2018)

8. Sunitinib in malignant melanoma: a treatment option only for KIT-mutated patients?. (December 2013)